Toxic leukoencephalopathy after heroin abuse without heroin vapor inhalation: MR imaging and clinical features in three patients.
OBJECTIVE
Toxic leukoencephalopathy has been associated with illicit heroin vapor inhalation. Despite the nonspecific and variable clinical presentation of these patients, they show typical radiologic findings. Previous studies evaluated typical radiologic findings with symmetric infratentorial hyperintense signal changes and similar alteration in the posterior limb of the internal capsule, the splenium of corpus callosum, the medial lemniscus and the lateral brainstem. In context with the reviewed literature, a series of another three cases with toxic leukoencephalopathy after heroin abuse other than vapor inhalation is presented.


METHODS
All three patients underwent magnet resonance imaging (MRI) including additional diffusion- weighted imaging and apparent diffusion coefficient maps. Clinical and laboratory findings were recorded.


RESULTS
MRI of all three patients revealed similar symmetric supratentorial hyperintense signal changes involving the frontal, parietal, occipital and temporal lobes. The cortex was spared and the subcortical U fibers were partially involved. Further, the brainstem and the cerebellar white matter were not affected.


CONCLUSIONS
Toxic leukoencephalopathy without involvement of the cerebellum and brainstem is a rare complication of heroin abuse. The pattern of heroin-induced toxic leukoencephalopathy on MRI might not only be related to an unknown adulterant, but also to the mode of drug administration.
Blasel
Stella
S
Institute of Neuroradiology, University of Frankfurt, Frankfurt, Germany, Stella.Blasel@kgu.de.
Hattingen
Elke
E
Adelmann
Michael
M
Nichtweiß
Michael
M
Zanella
Friedhelm
F
Weidauer
Stefan
S
D000280:Administration, Inhalation; D000328:Adult; D001933:Brain Stem / Q000187:drug effects / Q000473:pathology*; D002526:Cerebellar Diseases / Q000139:chemically induced / Q000473:pathology; D056324:Diffusion Tensor Imaging / Q000379:methods*; D003932:Heroin / Q000008:administration & dosage* / Q000506:poisoning; D006556:Heroin Dependence / Q000209:etiology* / Q000473:pathology*; D006801:Humans; D056784:Leukoencephalopathies / Q000139:chemically induced* / Q000473:pathology*; D008297:Male
D003932:Heroin